Standard Operating Procedure for Use of Internal Standards in LC-MS/MS Analysis for BA/BE Studies
| Department | BA-BE Studies |
|---|---|
| SOP No. | SOP/BA-BE/189/2025 |
| Supersedes | SOP/BA-BE/189/2022 |
| Page No. | Page 1 of 10 |
| Issue Date | 17/04/2025 |
| Effective Date | 20/04/2025 |
| Review Date | 17/04/2026 |
1. Purpose
To describe the procedure for selection, preparation, and use of internal standards in LC-MS/MS methods used for the quantitative determination of drug concentrations in biological matrices during BA/BE studies.
2. Scope
This SOP applies to all bioanalytical methods utilizing LC-MS/MS instrumentation for BA/BE studies performed in the bioanalytical laboratory. It covers the handling of internal standards
from procurement to application in study sample analysis.
3. Responsibilities
- Bioanalytical Scientist: Responsible for the selection, justification, and usage of internal standards during method development and sample analysis.
- QA Officer: Verifies that the internal standard procedures are followed, documented, and traceable.
- Lab Technician: Prepares internal standard solutions as per protocol and maintains inventory.
4. Accountability
The Bioanalytical Department Head is accountable for ensuring compliance with this SOP and verifying that the internal standard strategy aligns with regulatory expectations.
5. Procedure
5.1 Selection of Internal Standards
- Select an internal standard (IS) that closely resembles the chemical and physical properties of the analyte.
- Preferred internal standards include stable isotope-labeled analogs (e.g., deuterated compounds) or structurally similar compounds.
- Document justification of IS selection in method development records using Annexure-1: Internal Standard Selection Justification Form.
5.2 Procurement and Storage
- Source internal standards from certified suppliers with certificate of analysis (CoA).
- Upon receipt, verify the CoA for purity, molecular structure, and batch details.
- Store IS stock solution at recommended conditions (typically -20°C, protected from light).
- Record storage information in Annexure-2: Internal Standard Inventory Log.
5.3 Preparation of Internal Standard Solution
- Weigh required quantity of IS using calibrated analytical balance and dissolve in appropriate solvent (e.g., methanol or acetonitrile).
- Prepare intermediate and working solutions as per validated method SOPs.
- Label all prepared solutions with:
- Name of IS
- Concentration
- Date of preparation
- Expiry date
- Prepared by
- Document preparation details in Annexure-3: Internal Standard Solution Preparation Log.
5.4 Use During Sample Preparation
- Add a fixed volume of IS working solution to each calibration standard, quality control (QC) sample, and study sample prior to extraction.
- Ensure consistent mixing and processing to maintain uniformity.
- Record volumes and sample IDs in the extraction worksheet or Annexure-4: Sample Extraction Log.
5.5 Monitoring and Troubleshooting
- Review peak shape, retention time, and area response of the IS in each chromatogram.
- Investigate deviations such as inconsistent IS response or peak shifts.
- Document any issues and corrective actions taken in Annexure-5: Internal Standard Performance Review Log.
5.6 Disposal of Expired Standards
- Dispose of expired IS solutions as per hazardous waste SOPs.
- Record disposal activity in Annexure-6: Internal Standard Disposal Log.
6. Abbreviations
- IS: Internal Standard
- LC-MS/MS: Liquid Chromatography Tandem Mass Spectrometry
- BA/BE: Bioavailability/Bioequivalence
- CoA: Certificate of Analysis
- QC: Quality Control
- SOP: Standard Operating Procedure
7. Documents
- Internal Standard Selection Justification Form – Annexure-1
- Internal Standard Inventory Log – Annexure-2
- Internal Standard Solution Preparation Log – Annexure-3
- Sample Extraction Log – Annexure-4
- Internal Standard Performance Review Log – Annexure-5
- Internal Standard Disposal Log – Annexure-6
8. References
- ICH M10: Bioanalytical Method Validation
- US FDA Guidance on Bioanalytical Method Validation (2022)
- WHO Guidelines for Bioanalytical Laboratories
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | |||
| Department |
11. Annexures
Annexure-1: Internal Standard Selection Justification Form
| Analyte | Selected IS | Justification | Selected By | Date |
|---|---|---|---|---|
| Drug A | Drug A-d5 | Stable isotope, same retention time | Dr. Rajesh Kumar | 15/04/2025 |
Annexure-2: Internal Standard Inventory Log
| IS Name | Batch No. | Received Date | Expiry Date | Quantity | Location |
|---|---|---|---|---|---|
| Drug A-d5 | DAI-1125 | 10/04/2025 | 09/04/2026 | 25 mg | Freezer-1 |
Annexure-3: Internal Standard Solution Preparation Log
| Date | IS Name | Concentration | Solvent | Prepared By |
|---|---|---|---|---|
| 12/04/2025 | Drug A-d5 | 1 µg/mL | Methanol | Sunita Reddy |
Annexure-4: Sample Extraction Log
| Sample ID | IS Volume Added | Operator | Date |
|---|---|---|---|
| PL-101 | 50 µL | Ajay Verma | 14/04/2025 |
Annexure-5: Internal Standard Performance Review Log
| Date | Run ID | IS Peak Area | Observation | Action Taken |
|---|---|---|---|---|
| 15/04/2025 | BAE-097 | 325000 | Consistent | None |
Annexure-6: Internal Standard Disposal Log
| Date | IS Name | Quantity Disposed | Disposed By | Verified By |
|---|---|---|---|---|
| 17/04/2025 | Drug A-d5 | 5 mg | Mahesh Patil | QA Officer |
Revision History:
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 01/01/2022 | 1.0 | Initial Issue | New SOP | QA Head |
| 17/04/2025 | 2.0 | Expanded procedure and annexures added | ICH M10 Alignment | QA Head |